Emergent BioSolutions Inc.’s U.S. Health and Human Services contract to help produce flu vaccines in the event of a pandemic are key to the firm’s expansion, Chief Financial Officer Robert G. Kramer says.
The Baltimore Development Corp. on Wednesday confirmed that it is offering a second $250,000 new job creation tax incentive to Emergent.
{iframe}http://www.bizjournals.com/baltimore/blog/real-estate/2013/12/emergent-biosolutions-could-invest-up.html{/iframe}